Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection: Fulfilling the Potential on the Road to Elimination.
Publication
, Journal Article
Naggie, S; Wyles, D
Published in: J Infect Dis
November 27, 2020
Duke Scholars
Published In
J Infect Dis
DOI
EISSN
1537-6613
Publication Date
November 27, 2020
Volume
222
Issue
Suppl 9
Start / End Page
S741 / S744
Location
United States
Related Subject Headings
- World Health Organization
- Treatment Outcome
- Microbiology
- Humans
- Hepatitis C
- Global Health
- Disease Eradication
- Antiviral Agents
- 42 Health sciences
- 32 Biomedical and clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Naggie, S., & Wyles, D. (2020). Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection: Fulfilling the Potential on the Road to Elimination. J Infect Dis, 222(Suppl 9), S741–S744. https://doi.org/10.1093/infdis/jiaa425
Naggie, Susanna, and David Wyles. “Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection: Fulfilling the Potential on the Road to Elimination.” J Infect Dis 222, no. Suppl 9 (November 27, 2020): S741–44. https://doi.org/10.1093/infdis/jiaa425.
Naggie S, Wyles D. Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection: Fulfilling the Potential on the Road to Elimination. J Infect Dis. 2020 Nov 27;222(Suppl 9):S741–4.
Naggie, Susanna, and David Wyles. “Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection: Fulfilling the Potential on the Road to Elimination.” J Infect Dis, vol. 222, no. Suppl 9, Nov. 2020, pp. S741–44. Pubmed, doi:10.1093/infdis/jiaa425.
Naggie S, Wyles D. Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection: Fulfilling the Potential on the Road to Elimination. J Infect Dis. 2020 Nov 27;222(Suppl 9):S741–S744.
Published In
J Infect Dis
DOI
EISSN
1537-6613
Publication Date
November 27, 2020
Volume
222
Issue
Suppl 9
Start / End Page
S741 / S744
Location
United States
Related Subject Headings
- World Health Organization
- Treatment Outcome
- Microbiology
- Humans
- Hepatitis C
- Global Health
- Disease Eradication
- Antiviral Agents
- 42 Health sciences
- 32 Biomedical and clinical sciences